Molecular Epidemiology of Community-Associated MRSA

描述（由申请方提供）：金黄色葡萄球菌是一种多功能病原体，已成功适应并进化为产生多种毒力因子，使其能够定植并随后引起人类多种疾病。耐甲氧西林表皮葡萄金黄色葡萄球菌（MRSA），曾经是现代医院的主要祸害，在社区环境中没有任何已知的危险因素的人群中找到了一席之地。我们的长期研究目标是了解影响社区相关MRSA（CA-MRSA）流行病学变化的遗传因素。我们对该应用的具体假设是，1998年的高毒力“原型”CA-MRSA菌株MW 2（1998年在美国北达科他州的一名16个月大的美国印第安女孩中引起致命性败血症）从特定的威斯康星州CA-MRSA主要克隆群-2（MCG-2）进化而来，MCG-2于1992年首次在威斯康星州的美洲土著社区（NAC）中分离。我们进一步假设MCG-2菌株已经进化到从甲氧西林敏感的S.金黄色葡萄球菌（MSSA）菌株，使他们成为更具适应性，成功和致命的病原体。具体目标是：1）确定属于MCG-2的早期（1992）CA-MRSA菌株是否是成功的CA-MRSA菌株MW 2的祖先。具体地说，我们将确定来自威斯康星州的两种美洲土著CA-MRSA菌株WI-34和WI-99是否是MW 2的祖菌株.我们将比较WI-34和WI-99的基因组，与“原型”CA-MRSA，MW 2菌株的基因组，使用来自AffyphoInc.的定制MW 2基因芯片。此外，我们将通过几种基因型方法对WI-34和WI-99进行彻底的基因型分析。2)确定当代CA-MRSA菌株是否属于克隆组，MCG-2从威斯康星州5个NAC中流行的MSSA菌株进化而来。我们将进行基因分型：i）来自MCG-2的75株MRSA ii）75株NAC-MSSA菌株iii）来自非NAC的75株MSSA菌株，（回顾性收集），iv）75个最近收集的NAC-CA-MRSA（2002-04年）和v）20种过渡性MRSA菌株（回顾性收集），通过脉冲场凝胶电泳（PFGE）、多位点序列分型（MLST）、葡萄球菌盒式染色体mec（SCCmec），SPA和COA类型。3)确定当代CA-MRSA是否通过从其他MRSA/MSSA获得额外的毒力因子而进化或继续进化，成为广泛成功的病原体。我们将确定目标2中列出的所有320株分离株中40种不同毒力因子基因的存在或缺失，并确定当代CA-MRSA毒力因子基因的进化。

DESCRIPTION (provided by applicant): Staphylococcus aureus is a versatile pathogen that has successfully adapted and evolved to produce a variety of virulence factors that allow it to colonize and subsequently cause a variety of diseases in humans. Methicillin-resistant S. aureus (MRSA), once a scourge of modern hospitals primarily, has found a niche in community settings in people without any known risk factors. Our long-term research goal is to understand the genetic factors that are influencing the changing epidemiology of community-associated MRSA (CA- MRSA). Our specific hypothesis for this application is that the 1998 hypervirulent 'prototype' CA-MRSA strain, MW2 (caused fatal septicemia in a 16-month old American Indian girl in 1998 in North Dakota, USA), evolved from a specific Wisconsin CA-MRSA major clonal group-2 (MCG-2), which was first isolated in 1992 in a Native American community (NAC) in Wisconsin. We further hypothesize that the MCG-2 strains have evolved to acquire specific genetic traits from methicillin-sensitive S. aureus (MSSA) strain in NACs that allowed them to become more adaptable, successful, and virulent pathogens. The specific aims are to: 1) Determine if the early (1992) CA-MRSA strains belonging to the MCG-2 are the progenitors of the successful CA-MRSA strain, MW2. Specifically, we will determine if the two Native American CA- MRSA strains, WI-34 and WI-99, from Wisconsin were the progenitor strains of MW2. We will compare the genomes of WI-34 and WI-99, with that of the 'prototype' CA-MRSA, MW2 strain using a custom-made MW2 GeneChip¿ from Affymetrix Inc. Additionally, we will thoroughly genotype WI-34 and WI-99 by several genotypic methods. 2) Determine whether or not contemporary CA-MRSA strains belonging to clonal group, MCG-2 evolved from MSSA strains circulating in five NACs in Wisconsin. We will genotype: i) 75 MRSA from MCG-2 (retrospective collection), ii) 75 NAC-MSSA strains (retrospective collection), iii) 75 MSSA strains from a non-NAC (retrospective collection), iv) 75 most recently collected NAC-CA-MRSA (years 2002-04) and v) 20 transitional MRSA strains (retrospective collection) that have some but not all features of CA- MRSA by pulsed-field gel electrophoresis (PFGE), multilocus sequence type (MLST), staphylococcal cassette chromosome mec (SCCmec), spa and coa typing. 3) Determine whether or not the contemporary CA-MRSA have evolved or continue to evolve by acquiring additional virulence factors from other MRSA/MSSA to become a widely successful pathogen. We will determine the presence or absences of 40 different virulence factor genes in all 320 isolates listed in aim 2 and determine evolution of virulence factor genes in contemporary CA-MRSA.